Advances in MDS.
Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Mich., USA.
Charles A
CA
Schiffer
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D042381:Granulocyte Precursor Cells / Q000166:cytology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy*; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004921:Erythropoietin; D013792:Thalidomide; D000077269:Lenalidomide